Study highlights long-term survival & side effect issues of adjuvant breast cancer therapy


New data published in the Journal of Clinical Oncology show ELLENCE® (epirubicin hydrochloride injection) based chemotherapy regimen has survival benefits with low risk of adverse cardiac events

Source: Eurekalert & others

Last reviewed: By John M. Grohol, Psy.D. on 21 Feb 2009
    Published on All rights reserved.



When you get to the end of your rope, tie a knot and hang on.
-- Franklin D. Roosevelt
Stumble This Article Print Email
Subscribe to Our Weekly Newsletter

Users Online: 10317
Join Us Now!


Find a Therapist
Enter ZIP or postal code